ConductScience.org, home

Paper20879880

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.

Baker DL and 15 others. N Engl J Med, 2010. Cited by 228 papers, by iCite.

Cite this record

ConductScience Library. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. Papers, record 20879880. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20879880

Download JSON
Disease
neuroblastoma173 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
PubMed
Journal
N Engl J Med
PubMed
Year
2010
PubMed
Publication types
Clinical Trial, Phase III, Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
228
iCite
Relative citation ratio, by iCite
6.12
iCite
Revised in PubMed
2026-05-18
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baker DLDavid L
2Schmidt MLMary L
3Cohn SLSusan L
4Maris JMJohn M
5London WBWendy B
6Buxton AAllen
7Stram DDaniel
8Castleberry RPRobert P
9Shimada HHiroyuki
10Sandler AAnthony
11Shamberger RCRobert C
12Look ATA Thomas
13Reynolds CPC Patrick
14Seeger RCRobert C
15Matthay KKKatherine K
16Children’s Oncology GroupGroup

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
NeuroblastomaMajor topic
Carboplatin
Child
Child, Preschool
Cyclophosphamide
Doxorubicin
Etoposide
Humans
Infant
Intention to Treat Analysis
Neoplasm Staging
Prospective Studies
Survival Analysis
Treatment Outcome

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
UI0-CA29139NCI NIH HHSUnited StatesU10CA029139PubMed and NIHNIH RePORTER
U10 CA098413NCI NIH HHSUnited StatesU10CA098413PubMed and NIHNIH RePORTER
UI0-CA98413NCI NIH HHSUnited StatesU10CA098413PubMed and NIHNIH RePORTER
UI0-CA98543NCI NIH HHSUnited StatesU10CA098543PubMed and NIHNIH RePORTER
U10 CA029139NCI NIH HHSUnited StatesU10CA029139PubMed and NIHNIH RePORTER
U10 CA098543NCI NIH HHSUnited StatesU10CA098543PubMed and NIHNIH RePORTER
U10 CA017829NCI NIH HHSUnited StatesU10CA017829PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00003093Combination Chemotherapy in Treating Children With NeuroblastomaResultsYes

Source ClinicalTrials.gov

Download CSV of trials

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11323992Cisplatin therapy in infants: short and long-term morbidity.Br J Cancer Suppl1992https://conductscience.org/library/papers/1323992PubMed
27620924Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastoma.J Pediatr Hematol Oncol1995https://conductscience.org/library/papers/7620924PubMed
36738617Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma.N Engl J Med1984https://conductscience.org/library/papers/6738617PubMed
418349403Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.J Clin Oncol2008https://conductscience.org/library/papers/18349403PubMed
51579408Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group.Pediatrics1992https://conductscience.org/library/papers/1579408PubMed
69060959Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.J Natl Cancer Inst1997https://conductscience.org/library/papers/9060959PubMed
717035650Chronic health conditions in adult survivors of childhood cancer.N Engl J Med2006https://conductscience.org/library/papers/17035650PubMed
89516866Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group.Eur J Cancer1997https://conductscience.org/library/papers/9516866PubMed
92045858Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.J Clin Oncol1991https://conductscience.org/library/papers/2045858PubMed
102066755Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.J Clin Oncol1991https://conductscience.org/library/papers/2066755PubMed
117553646Significance of chromosome 1p loss of heterozygosity in neuroblastoma.Cancer Res1995https://conductscience.org/library/papers/7553646PubMed
1210490829Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.Oncogene1999https://conductscience.org/library/papers/10490829PubMed
1317586306Neuroblastoma.Lancet2007https://conductscience.org/library/papers/17586306PubMed
149626197
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
J Clin Oncol1998https://conductscience.org/library/papers/9626197PubMed
159552023Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.J Clin Oncol1998https://conductscience.org/library/papers/9552023PubMed
1617974716Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group.Pediatrics2007https://conductscience.org/library/papers/17974716PubMed
1716314642Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.J Clin Oncol2005https://conductscience.org/library/papers/16314642PubMed
1819047290The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.J Clin Oncol2009https://conductscience.org/library/papers/19047290PubMed
1919047291The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.J Clin Oncol2009https://conductscience.org/library/papers/19047291PubMed
208176583The surgical challenge of neuroblastoma.J Pediatr Surg1994https://conductscience.org/library/papers/8176583PubMed

See all 44 referencesDownload CSV of references

Cited by133

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.

PMIDTitleJournalYearIn PapersSource
42591963Vasoactive Intestinal Peptide (VIP)-Secreting Neuroblastic Tumors in Children Presenting With Chronic Secretory Diarrhea: A Report of Two Cases.Cureus2026https://conductscience.org/library/papers/42591963PubMed
42449647Strategies to Improve Sensitivity to Radiotherapy in Pediatric Solid Tumors.Cancers (Basel)2026https://conductscience.org/library/papers/42449647PubMed
42385103Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.JCO Precis Oncol2026https://conductscience.org/library/papers/42385103PubMed
42277674Clinical analysis and prognostic factors in children with neuroblastoma-associated opsoclonus-myoclonus syndrome: a multicenter retrospective study.BMC Cancer2026https://conductscience.org/library/papers/42277674PubMed
41958679Mechanism by which SAHA regulates HLA-E expression via the endoplasmic reticulum stress-related PERK/ATF4/CHOP pathway in neuroblastoma.Front Immunol2026https://conductscience.org/library/papers/41958679PubMed
41682783Neuroblastoma in Childhood: Biological Insights, Risk Stratification, and Advances in Multimodal Therapy.J Clin Med2026https://conductscience.org/library/papers/41682783PubMed
41545871Activation of the pituitary adenylate cyclase-activating polypeptide type I receptor promotes neuroblastoma proliferation and migration through distinct G protein pathways.Cell Commun Signal2026https://conductscience.org/library/papers/41545871PubMed
41530803The safety and efficacy of GD2-targeted CAR-T cells in patients with neuroblastoma: a systematic review and meta-analysis.Eur J Med Res2026https://conductscience.org/library/papers/41530803PubMed
41392230Lessons learned from different prognostic factors analysis in intermediate-risk neuroblastoma: ten years' experience at a tertiary center.J Egypt Natl Canc Inst2025https://conductscience.org/library/papers/41392230PubMed
41231348
Busulfan and melphalan (Bu-Mel) versus carboplatin, etoposide, and melphalan (CEM) conditioning regimens for autologous haematopoietic stem cell transplant in children and young adults with high-risk neuroblastoma.
Cochrane Database Syst Rev2025https://conductscience.org/library/papers/41231348PubMed
40787276Therapeutic Innovation in Pediatric Neuroblastoma: Age and Stage-Specific Strategies from Prenatal to Early Childhood-A Review Article.Iran J Child Neurol2025https://conductscience.org/library/papers/40787276PubMed
40539008Horner syndrome in a pediatric patient.Pediatr Investig2025https://conductscience.org/library/papers/40539008PubMed
40351327Characteristics, treatments, and outcomes of adolescents and adults with neuroblastoma: a retrospective study in China.Ther Adv Med Oncol2025https://conductscience.org/library/papers/40351327PubMed
40163752Associations between Tumor Ploidy and Overall Survival in Pediatric Neuroblastoma.P R Health Sci J2025https://conductscience.org/library/papers/40163752PubMed
39981455Development of Neuroblastoma During Growth Hormone Therapy for Short Stature in a Girl With Mosaic Turner Syndrome.Cureus2025https://conductscience.org/library/papers/39981455PubMed
39796644Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic Review.Cancers (Basel)2024https://conductscience.org/library/papers/39796644PubMed
39725722Impact of the relationship between renal pedicles and tumors on surgical outcomes for non-high-risk abdominal neuroblastoma.Pediatr Surg Int2024https://conductscience.org/library/papers/39725722PubMed
39594898Unveiling Tumorigenesis Mechanisms and Drug Therapy in Neuroblastoma by Mass Spectrometry Based Proteomics.Children (Basel)2024https://conductscience.org/library/papers/39594898PubMed
39317567Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.J Pediatr Surg2025https://conductscience.org/library/papers/39317567PubMed
39199637Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma.Cancers (Basel)2024https://conductscience.org/library/papers/39199637PubMed

See all 133 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440NCBI Gene
FANCL55120PubTator's text mininghttps://conductscience.org/library/genes/55120NCBI Gene
MYCN4613PubTator's text mininghttps://conductscience.org/library/genes/4613NCBI Gene

Download CSV of genes

Drugs6

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
CYCLOPHOSPHAMIDECHEMBL1200796Results1https://conductscience.org/library/drugs/CHEMBL1200796ChEMBL
FILGRASTIMCHEMBL1201567Results1https://conductscience.org/library/drugs/CHEMBL1201567ChEMBL
SARGRAMOSTIMCHEMBL1201670Results1https://conductscience.org/library/drugs/CHEMBL1201670ChEMBL
CARBOPLATINCHEMBL1351Results1https://conductscience.org/library/drugs/CHEMBL1351ChEMBL
DOXORUBICIN HYDROCHLORIDECHEMBL359744Results1https://conductscience.org/library/drugs/CHEMBL359744ChEMBL
ETOPOSIDECHEMBL44657Results1https://conductscience.org/library/drugs/CHEMBL44657ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20879880

GET https://conductscience.org/api/papers/v1/20879880/references?page=2